Overview
Philip Abbosh is an Oncologist in Philadelphia, Pennsylvania. Dr. Abbosh is highly rated in 6 conditions, according to our data. His top areas of expertise are Bladder Cancer, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Cystectomy, and Nephrectomy. Dr. Abbosh is currently accepting new patients.
His clinical research consists of co-authoring 45 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1200 West Tabor Road, 3rd Floor Sley, Philadelphia, PA 19141
9880 Bustleton Avenue, Suite 220, Philadelphia, PA 19115
Additional Areas of Focus
Dr. Abbosh has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Temple Faculty Practice Plan Inc
Robert Uzzo is a Urologist in Philadelphia, Pennsylvania. Dr. Uzzo is highly rated in 23 conditions, according to our data. His top areas of expertise are Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Renal Oncocytoma, Nephrectomy, and Cystectomy.
Penn Urology Perelman
Trinity Bivalacqua is a Urologist in Philadelphia, Pennsylvania. Dr. Bivalacqua is highly rated in 24 conditions, according to our data. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Prostatectomy.
Temple Faculty Practice Plan Inc
Alexander Kutikov is a Urologist in Philadelphia, Pennsylvania. Dr. Kutikov is highly rated in 26 conditions, according to our data. His top areas of expertise are Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Bladder Cancer, Nephrectomy, and Cystectomy.
Frequently Asked Questions about Dr. Philip Abbosh
How do I make an appointment with Dr. Philip Abbosh?
You can book an appointment with Dr. Philip Abbosh by calling their office at 215-663-6067. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Philip Abbosh a top-rated expert for Bladder Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Philip Abbosh is classified as an Distinguished expert for Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Philip Abbosh specialize in?
While Dr. Philip Abbosh is a Urology, they have specific expertise in Bladder Cancer, Chromophobe Renal Cell Carcinoma, and Cystectomy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Urology.
Does Dr. Philip Abbosh participate in research or clinical trials?
Yes. Dr. Philip Abbosh has published 45 articles and abstracts on conditions like Bladder Cancer. You can view a list of Dr. Philip Abbosh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Philip Abbosh accept my insurance?
Dr. Philip Abbosh accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 215-663-6067 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Bladder CancerDr. Abbosh isDistinguished. Learn about Bladder Cancer.
- Chromophobe Renal Cell CarcinomaDr. Abbosh isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Advanced
- CystectomyDr. Abbosh isAdvanced. Learn about Cystectomy.
- Muscle Invasive Bladder CancerDr. Abbosh isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Renal Cell Carcinoma (RCC)Dr. Abbosh isAdvanced. Learn about Renal Cell Carcinoma (RCC).
- Urothelial CancerDr. Abbosh isAdvanced. Learn about Urothelial Cancer.
- Experienced
- BalanitisDr. Abbosh isExperienced. Learn about Balanitis.
- Bilateral HydronephrosisDr. Abbosh isExperienced. Learn about Bilateral Hydronephrosis.
- Bladder StonesDr. Abbosh isExperienced. Learn about Bladder Stones.
- BoilsDr. Abbosh isExperienced. Learn about Boils.
- CarbuncleDr. Abbosh isExperienced. Learn about Carbuncle.
- EmpyemaDr. Abbosh isExperienced. Learn about Empyema.